Efficacy of an integrative treatment (Personalised Integrative Therapy) for depression and / or anxiety in adults: a randomised controlled pilot trial

Murdoch University0 个研究点目标入组 48 人开始时间: 2019年3月19日最近更新: 2019年9月30日

适应症

试验速览

暂无简介。

•1. Adults (male and female) aged between 18 and 65 years
•2. Self-reported mild-to-moderate depression and/or anxiety as assessed by the DASS
•3. Fluent in English
•4. Willing to provide a personally signed and dated informed consent form detailing all pertinent aspects of the trial.
•5. Willing and able to participate in this 12-week study (6 active weeks plus 6-week follow-up)
•6. If taking pharmaceutical medications (including antidepressants) must be on a stable dose for the last 8-weeks. All participants should continue to take their pharmaceutical medications as prescribed by their treating doctor during the trial.

•1. DSM-5 diagnosis including but not limited to bipolar disorder, schizophrenia, psycho-organic syndromes, eating disorders, substance abuse or dependence disorders.
•2. At significant risk of suicide or engaging in self-harm behaviours.
•3. Suffering from major medical illness impacting on ability to implement many lifestyle, dietary, and psychological changes covered in the program. Medical disorders include but are not limited to cancers, serious cardiovascular disease, neurodegenerative disorders (e.g., Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease), and unmanaged metabolic disorders such as diabetes.
•4. Currently receiving psychological therapy for depression or anxiety by a mental health practitioner
•5. Currently taking greater than 2 natural supplements that are included in the PI + supplements condition
•6. Known allergy or significant intolerance to natural supplements

发起方